Silvia T Cardona Selected Research

phenylacetyl-coenzyme A (phenylacetyl-CoA)

11/2014	The attenuated virulence of a Burkholderia cenocepacia paaABCDE mutant is due to inhibition of quorum sensing by release of phenylacetic acid.
9/2011	Phenylalanine induces Burkholderia cenocepacia phenylacetic acid catabolism through degradation to phenylacetyl-CoA in synthetic cystic fibrosis sputum medium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia T Cardona Research Topics

Disease

10	Infections 09/2019 - 11/2005
8	Cystic Fibrosis (Mucoviscidosis) 01/2019 - 09/2011
1	Acinetobacter Infections 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Hypersensitivity (Allergy) 01/2017
1	Salmonella Infections (Salmonellosis) 05/2015
1	Community-Acquired Infections 01/2015
1	Persistent Infection 12/2011
1	Polyps 10/2002

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 11/2005
4	phenylacetic acid (phenylacetate)FDA Link 05/2017 - 11/2008
2	Pharmaceutical PreparationsIBA 01/2018 - 10/2016
2	Amino Acids FDA Link 01/2018 - 09/2011
2	Phenylalanine (L-Phenylalanine)FDA Link 05/2017 - 09/2011
2	phenylacetyl-coenzyme A (phenylacetyl-CoA)IBA 11/2014 - 09/2011
1	Novobiocin (Streptonivicin)FDA Link 01/2017
1	Lamotrigine (Lamictal)FDA LinkGeneric 05/2015
1	Mixed Function Oxygenases (Monooxygenases)IBA 11/2014
1	dornase alfa (Pulmozyme)FDA Link 02/2012
1	Anti-Infective Agents (Microbicides)IBA 02/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2011
1	Coenzyme A (CoA)IBA 01/2011
1	PolymersIBA 10/2002
1	EnzymesIBA 10/2002
1	PolyphosphatesIBA 10/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2015
1	Catheters 01/2022